|
Jun 25
|
MaaT Pharma Announces Initiation of Coverage of its Stock by Stifel with a Buy Rating and a Target Price of EUR 16
|
|
Jun 24
|
MaaT Pharma Appoints Gianfranco Pittari, M.D. Ph.D, as Chief Medical Officer
|
|
Dec 5
|
MaaT Pharma : Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
|
|
Nov 30
|
MaaT Pharma, Leader in Development of Microbiome-Based Therapies in Oncology, Awarded Government Funding for Clinical Development of MaaT033 as part of the France 2030 Plan
|
|
Sep 8
|
MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
|
|
Sep 7
|
MaaT Pharma Announces European Medicines Agency Granted MaaT033 Orphan Drug Designation aiming to improve overall survival in patients undergoing Hematopoietic Stem Cell transplantation
|
|
Jul 20
|
MaaT Pharma Joins Microbiome Therapeutics Innovation Group
|